Clinical trial
Dose Escalation For INtraprostatic LEsions
NCT05851547
Study timeline
Study start (actual)2023-11-23Date precision: day
Registry last updated2024-01-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostatic Neoplasmsunresolved
Interventions
Prostate SBRT with Focal BoostRADIATION
Triptorelin InjectionDRUG · verified · RxNorm: triptorelin Injection
Sponsors & collaborators
Ottawa Hospital Research Institutelead sponsor
Knight Therapeutics (USA) Inccollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05851547 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.